左旋倍他洛尔 T6565
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
25 mg | 116209-55-3 | ¥397.00 | 询底价 |
10 mg | 116209-55-3 | ¥235.00 | 询底价 |
100 mg | 116209-55-3 | ¥968.00 | 询底价 |
50 mg | 116209-55-3 | ¥658.00 | 询底价 |
200 mg | 116209-55-3 | ¥1,430.00 | 询底价 |
1 mL | 116209-55-3 | ¥242.00 | 询底价 |
500 mg | 116209-55-3 | ¥2,420.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Levobetaxolol hydrochloride
描述: Levobetaxolol hydrochloride ((S)-Betaxolol hydrochloride) 是 β-肾上腺素能受体抑制剂 (β阻滞剂) 。它具有降低眼压的作用,可用于研究青光眼。
体外活性: Levobetaxolol potently antagonizes functional activities at cloned human β1 and β2 receptors, and also at guinea pig atrial β1, tracheal β2 and rat colonic β3 receptors with IC50s of 33.2 nM, 2970 nM and 709 nM, respectively. Levobetaxolol (Ki = 16.4 nM) is more potent than dextrobetaxolol (Ki = 2.97 μM) at inhibiting isoproterenol-induced cAMP production in human non-pigmented ciliary epithelial cells. [1] Levobetaxolol (topically applied) has been shown to reach the back of the eye in sufficient quantities to protect retinal ganglion cells from various types of insults. Levobetaxolol displaces [3H]-nitrendipine for L-type voltage-dependent calcium channel receptor with IC50 of 29.5 μM in rat cortex. Levobetaxolol reduces NMDA-stimulated 45Ca2+ influx by 47.3%. Levobetaxolol (topically applied) reduces the b-wave amplitude caused by ischaemia/reperfusion. [2]
体内活性: Levobetaxolol (150 mg/eye) is more potent than dextrobetaxolol, reducing intraocular pressure by 25.9% in conscious ocular hypertensive cynomolgus monkeys. [1] Levobetaxolol (20 mg/kg) significant protects retinal function and results in significantly thicker the RPE and outer nuclear layer in a photic-induced retinopathy rat model. Levobetaxolol (20 mg/kg) results in a 10-fold up-regulation of bFGF and a two-fold up-regulation of CNTF mRNA levels, trophic factors that have been shown to inhibit retinal degeneration in a number of species. [3]
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 64 mg/mL (186.1 mM)
Ethanol : 64 mg/mL (186.1 mM)
H2O : 63 mg/mL (183.2 mM)
关键字: Adrenergic Receptor | Levobetaxolol hydrochloride | Levobetaxolol | Inhibitor | (S)-Betaxolol | inhibit | Betaxolol Hydrochloride | Levobetaxolol Hydrochloride | Beta Receptor
相关产品: Dexmedetomidine hydrochloride | Conopeptide rho-TIA | Muscarinic toxin 3 | AVN-101 | Deoxycorticosterone acetate | Synephrine hydrochloride | Lofexidine | Faxeladol | Brefonalol HCl | Guanfacine hydrochloride
相关库: Anti-Neurodegenerative Disease Compound Library | Drug Repurposing Compound Library | Anti-Cancer Drug Library | Membrane Protein-targeted Compound Library | Neuronal Signaling Compound Library | Anti-Cancer Clinical Compound Library | GPCR Compound Library | Inhibitor Library | Anti-Cancer Approved Drug Library | Bioactive Compound Library
左旋倍他洛尔 T6565信息由TargetMol中国为您提供,如您想了解更多关于左旋倍他洛尔 T6565报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途